SBI Securities’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$408 Hold
30
– – ﹤0.01% 3181
2026
Q2
$465 Hold
30
– – ﹤0.01% 3056
2026
Q1
$193 Hold
30
– – ﹤0.01% 3233
2025
Q4
$318 Hold
30
– – ﹤0.01% 3047
2025
Q3
$657 Hold
30
– – ﹤0.01% 2865
2025
Q2
$975 Hold
30
– – ﹤0.01% 2689
2025
Q1
$621 Buy
+30
New +$1K ﹤0.01% 2778

Other funds holding MTRI

SBI Securities's MTRI Position: Q3 2026 in Review

SBI Securities held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 30 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #3181.

SBI Securities first reported a position in MTRI in Q1 2025 and has held it in 7 quarters since. The position peaked at $975 in Q2 2025. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • SBI Securities held 30 shares of Mentari Therapeutics, Inc. Common Stock worth $408 as of Q3 2026.
  • SBI Securities left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
  • Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3181 holding.
  • SBI Securities first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2025 and has held it in 7 quarters since.
  • SBI Securities's Mentari Therapeutics, Inc. Common Stock position peaked at $975 in Q2 2025.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.